{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:02:54Z","timestamp":1790859774323,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Women\u2019s health has historically lacked investment in research and development. Technologies that enhance women\u2019s health (\u2018FemTech\u2019) could contribute to improving this. However, there has been little work to understand which priority unmet needs should be a focus for women\u2019s health technology development. The voices of clinicians and those who experience and utilise these technologies (including those used at home or encountered in clinical settings) are needed to ensure that device development aligns with need, without risking exacerbating or creating health inequities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We undertook a priority setting partnership project exploring unmet needs in women\u2019s health and well-being where physical technologies or innovations could help. This comprised gathering feedback from: patients and clinicians using both qualitative surveys and discussions; collating and publishing these responses and asking for feedback; evidence checking unmet needs identified, and holding a partnership priority setting event to agree a top 10 and top 20 list of priorities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We generated a \u2018longlist\u2019 of 54 suggestions for areas where better kit, devices or equipment could support women\u2019s health. For three, we found evidence of existing technologies which mitigated against that need. We took the remaining 51 suggestions to a partnership priority setting meeting which brought together clinicians and service users. Through discussion as this group, we generated a list of the top 10 areas identified as priorities for technological development and improvement. These included better devices to manage examination, diagnosis and treatment of pelvic pain (including endometriosis), prolapse care, continence (treatment and prevention, related to pregnancy and beyond), menstruation, vaginal pain and vaginismus, point of care tests for common infections, and nipple care when breastfeeding.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The top priorities suggest far-reaching areas of unmet need across women\u2019s life course and across multiple domains of health and well-being, and opportunities where innovation in the devices that people use themselves or encounter in health settings could potentially enhance health and healthcare experiences.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02778-2","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T17:01:59Z","timestamp":1702486919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["What are important areas where better technology would support women\u2019s health? Findings from a priority setting partnership"],"prefix":"10.1186","volume":"23","author":[{"given":"Sharon","family":"Dixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"McNiven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Knox-Peebles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Taghinejadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"issue":"3","key":"2778_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2016-000080","volume":"1","author":"SA Peters","year":"2016","unstructured":"Peters SA, Woodward M, Jha V, Kennedy S, Norton R. Women's health: a new global agenda. BMJ Glob Health. 2016;1(3):1\u20138.","journal-title":"BMJ Glob Health."},{"key":"2778_CR2","volume-title":"Unwell women: a journey through medicine and myth in a man-made world","author":"E Cleghorn","year":"2022","unstructured":"Cleghorn E. Unwell women: a journey through medicine and myth in a man-made world. London: Weidenfeld & Nicolson; 2022."},{"issue":"11","key":"2778_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1089\/cyber.2021.29230.editorial","volume":"24","author":"BK Wiederhold","year":"2021","unstructured":"Wiederhold BK. Femtech: digital help for Women's health care across the life span. Cyberpsychol Behav Soc Netw. 2021;24(11):697\u20138.","journal-title":"Cyberpsychol Behav Soc Netw."},{"key":"2778_CR4","first-page":"54","volume-title":"Women's health strategy for England","author":"Anon.","year":"2022","unstructured":"Anon. Women's health strategy for England. London: GOV.UK; 2022. p. 54."},{"issue":"1","key":"2778_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/00346764.2021.2018027","volume":"80","author":"T Hendl","year":"2021","unstructured":"Hendl T, Jansky B. Tales of self-empowerment through digital health technologies: A closer look at \u2018femtech. Rev Soc Econ. 2021;80(1):29\u201357.","journal-title":"Rev Soc Econ."},{"issue":"3","key":"2778_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/medlaw\/fwac006","volume":"30","author":"C McMillan","year":"2022","unstructured":"McMillan C. Monitoring female fertility through \u2018femtech\u2019: the need for a whole-system approach to regulation. Med Law Rev. 2022;30(3):410\u201333.","journal-title":"Med Law Rev."},{"key":"2778_CR7","first-page":"1","volume-title":"Adjunct Proceedings of the 2022 Nordic Human-Computer Interaction Conference","author":"T Almeida","year":"2022","unstructured":"Almeida T, Shipp L, Mehrnezhad M, Toreini E. Bodies like yours: Enquiring data privacy in Femtech. In: Adjunct Proceedings of the 2022 Nordic Human-Computer Interaction Conference; 2022. p. 1\u20135."},{"key":"2778_CR8","first-page":"145","volume":"2022","author":"M Mehrnezhad","year":"2022","unstructured":"Mehrnezhad M, Shipp L, Almeida T, Toreini E. Vision: too little too late? Do the risks of Femtech already outweigh the benefits? Eur Symp Usable Security. 2022;2022:145\u201350.","journal-title":"Eur Symp Usable Security."},{"issue":"4","key":"2778_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/GME.0000000000001742","volume":"28","author":"SS Faubion","year":"2021","unstructured":"Faubion SS. Femtech and midlife women's health: good, bad, or ugly? Menopause. 2021;28(4):347\u20138.","journal-title":"Menopause."},{"key":"2778_CR10","doi-asserted-by":"crossref","unstructured":"Gutterman A. Femtech and older women. SSRN Electron J. 2023:1\u201314.","DOI":"10.2139\/ssrn.4372007"},{"key":"2778_CR11","doi-asserted-by":"publisher","first-page":"3\u201316","DOI":"10.1088\/978-0-7503-2312-3","volume-title":"Predictive analytics in healthcare","author":"V Subbhuraam","year":"2021","unstructured":"Subbhuraam V. FemTech solutions for advancing women\u2019s health: transforming the future of medicine. In: Predictive analytics in healthcare. Bristol England: IOP Publishing; 2021. p. 3\u201316\u20137."},{"key":"2778_CR12","unstructured":"Technology readiness level definitions - NASA [internet]. NASA; [cited 2023 May 1]. Available from: https:\/\/www.nasa.gov\/pdf\/458490main_TRL_Definitions.pdf"},{"key":"2778_CR13","unstructured":"Understanding technology readiness level for medical devices development [internet]. Tempo; 2021 [cited 2023 May 20]. Available from: https:\/\/www.tempoautomation.com\/blog\/understanding-technology-readiness-level-for-medical-devices-development\/"},{"key":"2778_CR14","first-page":"95","volume-title":"Women's health strategy for England","author":"Anon.","year":"2022","unstructured":"Anon. Women's health strategy for England. London: GOV.UK; 2022. p. 95."},{"key":"2778_CR15","unstructured":"What are the principles of the JLA? [Internet]. What are the principles of the JLA? | James Lind Alliance. [cited 2023Apr12]. Available from: https:\/\/www.jla.nihr.ac.uk\/jla-guidebook\/chapter-2\/what-are-the-principles-of-the-jla.htm#:~:text=transparency%20of%20process%2C%20methods%20and,other%20aspects%20of%20the%20process."},{"issue":"1","key":"2778_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-4505-8-1","volume":"8","author":"RF Viergever","year":"2010","unstructured":"Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for Health Research priority setting: nine common themes of good practice. Health Res Pol Syst. 2010;8(1):1\u20139.","journal-title":"Health Res Pol Syst."},{"issue":"6","key":"2778_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/1471-0528.16150","volume":"127","author":"L Graham","year":"2020","unstructured":"Graham L, Illingworth BJG, Showell M, Vercoe M, Crosbie EJ, Gingel LJ, et al. Research priority setting in women\u2019s health: a systematic review. BJOG Int J Obstet Gynaecol. 2020;127(6):694\u2013700.","journal-title":"BJOG Int J Obstet Gynaecol."},{"key":"2778_CR18","unstructured":"Problematic hip replacement [Internet]. 2022 [cited 2023 May 20]. Available from: https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/problematic-hip-replacement\/"},{"key":"2778_CR19","unstructured":"Digital Technology for adolescents and young persons with inflammatory bowel disease [Internet]. 2022 [cited 2023 May 20]. Available from: https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/digital-technology-for-adolescents-and-young-persons-with-inflammatory-bowel-disease\/"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02778-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T17:03:08Z","timestamp":1702486988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02778-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2778"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02778-2","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a patient and public involvement priority setting partnership project, developing suggestions for research needs. This project was conducted and reported in line with established PPIE guidance (NIHR Involve). The project and surveys were reviewed by the University of Oxford Medical Sciences ethical committee who deemed this project patient and public involvement, not research, and therefore, waived the requirement for formal ethical approvals including consent, because these were anonymous patient and public involvement and engagement questionnaires. Stakeholder conversations were not recorded or transcribed to ensure anonymity. This project was conducted in line with established James Lind Alliance methodology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of this manuscript. There are no other consents required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KV has received research funding from Bayer Healthcare and honoraria for talks and consultancy fees from Bayer Healthcare, AbbVie and Eli Lilly. The remaining authors declare no relevant COI.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"667"}}